Results 271 to 280 of about 89,230 (317)

Partial Splenic Embolization for Portal Hypertension Exacerbation During Atezolizumab/Bevacizumab Combination Therapy in Unresectable Hepatocellular Carcinoma. [PDF]

In Vivo
Ishikawa T, Terai N, Sato R, Natsui H, Iwasawa T, Ogawa M, Kobayashi Y, Sato T, Yokoyama J, Iiduka A, Honma T.   +10 more
europepmc   +1 more source

Portal hypertension in children

Current Problems in Surgery, 1966
openaire   +4 more sources

Phenotypical Characterization of Gastroenterological and Metabolic Manifestations in Patients With Williams–Beuren Syndrome

American Journal of Medical Genetics Part A, Volume 197, Issue 6, June 2025.
ABSTRACT Gastrointestinal (GI) symptoms are common in patients with Williams–Beuren syndrome (WBS), but their prevalence and possible causes are not yet fully known. This study assessed GI symptoms' prevalence and their possible origin by performing a predefined set of tests in adult WBS patients.
Maria Francesca Bedeschi, Annarita Baldassarri, Roberta Villa, Federico Tanzi, Simona Salera, Vincenza Lombardo, Alessandro Draghi, Nicole Piazza O'Sed, Giovanni Casazza, Maurizio Vecchi, Mirella Fraquelli   +10 more
wiley   +1 more source

Endogenous C-type natriuretic peptide offsets the pathogenesis of steatohepatitis, hepatic fibrosis, and portal hypertension. [PDF]

PNAS Nexus
Perez-Ternero C, Li W, Aubdool AA, Goldin RD, Loy J, Devalia K, Alazawi W, Hobbs AJ.   +7 more
europepmc   +1 more source

Elucidating the Molecular Landscape of Cystic Kidney Disease: Old Friends, New Friends and Some Surprises

American Journal of Medical Genetics Part A, Volume 197, Issue 6, June 2025.
ABSTRACT Cystic kidney diseases (CyKD) are a diverse group of disorders affecting more than 1 in 1000 individuals. Over 120 genes are implicated, primarily encoding components of the primary cilium, transcription factors, and morphogens. Prognosis varies greatly by molecular diagnosis. Causal variants are not identified in 10%–60% of individuals due to
Deborah Watson, Frank Mentch, Jonathan Billings, Kayleigh Ostberg, Michael E. March, Jennifer M. Kalish, Dong Li, India Cannon, Lisa M. Guay‐Woodford, Erum Hartung, Alanna Strong   +10 more
wiley   +1 more source

The effect of propranolol on gastrointestinal motility and permeability in patients with cirrhosis and significant portal hypertension. [PDF]

BMC Gastroenterol
Xirouchakis E, Kranidioti H, Hadziyanni E, Kourikou A, Reppas C, Vertzoni M, Papadopoulos N, Deutsch M, Papatheodoridis G, Manolakopoulos S.   +9 more
europepmc   +1 more source

Cholate Shunt, Oral Cholate Challenge and Endoscopic Lesions of Portal Hypertension: The SHUNT-V Study. [PDF]

Aliment Pharmacol Ther
Shiffman M, Reddy KR, Leise MD, Qureshi K, Smith AD, Helmke S, Kittelson J, McRae MP, Imperial JC, Everson GT, SHUNT‐V Investigators.   +10 more
europepmc   +1 more source

A Case of Robotic Cholecystectomy in a Patient With Decompensated Cirrhosis and Portal Hypertension. [PDF]

Cureus
Li MJ, Sprinkles KR, Elfedaly M, Soliman B.   +3 more
europepmc   +1 more source

Intertransverse Process Block With Catheter Placement for Postoperative Pain Management in a Patient With Alcoholic Liver Disease and Portal Hypertension: A Case Report. [PDF]

Cureus
Nakazawa K, Takenaka A, Suzuki T.
europepmc   +1 more source

Case report: Upper gastrointestinal bleeding associated with pancreatic segmental portal hypertension: six case reports and literature review. [PDF]

Front Med (Lausanne)
Miao Q, Zheng Z, Piao M, Cao H, Wang B, Liu W.   +5 more
europepmc   +1 more source